Human erythrocyte components

Human erythrocyte components refer to the collective set of proteins, lipids, and enzymes that make up the red blood cell (RBC) (Human Protein Atlas). The most prominent component is hemoglobin, which is responsible for the transport of oxygen and carbon dioxide throughout the body (StatPearls). Other vital components include the plasma membrane proteins (such as Band 3 and glycophorins) that maintain the cell's biconcave shape and flexibility, and cytosolic enzymes like glucose-6-phosphate dehydrogenase (G6PD) and carbonic anhydrase that manage oxidative stress and pH (UniProt). While not a single molecular target, these components are the focus of various therapeutic strategies: for instance, hemoglobin is targeted in sickle cell disease by drugs like voxelotor, and erythrocyte enzymes are targeted in metabolic or infectious diseases (PubChem). Furthermore, the erythrocyte serves as a host for Plasmodium parasites, making its internal environment a key site for antimalarial drug action (PubMed). Understanding these components is also critical for identifying safety risks, as many drugs can cause adverse effects like hemolysis or methemoglobinemia by interacting with RBC constituents.

Other names

Red blood cell componentsErythrocyte constituentsErythrocyte membrane and cytosolic proteins

Drugs targeting erythrocyte components act through various mechanisms: Voxelotor increases hemoglobin's affinity for oxygen to prevent sickling; acetazolamide inhibits carbonic anhydrase to affect fluid balance; antimalarials like chloroquine disrupt heme sequestration; and mitapivat activates pyruvate kinase to improve RBC survival.